Local Institution

Princeton, New Jersey 08543

0 studies enrolling now · 12 studies all time

What they study most

Cancer, Encephalitis, Heart Decompensation, Heart Failure, Juvenile Idiopathic Arthritis, Metastatic Colorectal Cancer (mCRC), Psoriatic Arthritis, Rheumatoid Arthritis, Stem Cell Transplantation, Stroke, Systemic Embolism, VTEt and VTEp, Venous Thromboembolism (VTE)

Studies at this site

• A Post-marketing Study to Assess the Safety of Abatacept in Sweden Using the Swedish Rheumatology Quality Register (SRQ) Register — Completed
• Study to Determine if the Flu Vaccine Increases the Risk of Muscle Damage in Participants Taking Drugs That Block Certain Proteins Made by Some Types of Immune System Cells — Completed
• A Study of Overall Survival in Participants With Metastatic Colorectal Cancer (mCRC) — Completed
• Study of the Sudden Heart Failure Participant Population in the US — Withdrawn before enrolling
• Risk Factors and Outcomes of Immune-Mediated Encephalitis Following Exposure to Nivolumab — Completed
• A Study to Assess 7/8 HLA-matched Hematopoietic Stem Cell Transplantation Participants Treated With or Without Abatacept in Combination With a Calcineurin Inhibitor and Methotrexate — Completed
• A Study to Determine the Risk of Cancer in Rheumatoid Arthritis (RA) Patients Who Use Abatacept and Other Biologic Agents — Completed
• A Study to Compare the Risk of a Major Bleeding in Participants Who Received Blood Thinning Medications Following a Blood Clot — Completed
• A Study of Juvenile Idiopathic Arthritis Patients Given Abatacept and the Number of Infections or Malignancies That Occur — Completed
• Safety Study of Abatacept in Rheumatoid Arthritis Participants — Completed
• A Study of Patients Hospitalized With Acute Heart Failure With Reduced Ejection Fraction (HFrEF) — Status unconfirmed
• Evaluation of the Effectiveness of Eliquis ® (Apixaban) Risk Minimization Tools in European Economic Area (EEA) Countries — Completed